News|Articles|April 2, 2004
- Pharmaceutical Technology-04-02-2004
- Volume 28
- Issue 4
April 2004
Author(s)Pharmaceutical Technology Editors
pharmaceutical science and technology news
Advertisement
Articles in this issue
almost 22 years ago
Spotlight on Business Riskalmost 22 years ago
Vibration Technology for Active Dry-Powder Inhalersalmost 22 years ago
In the Spotlight April 2004almost 22 years ago
FDA Attacks Counterfeitsalmost 22 years ago
Synthetic Excipients Challenge All-Natural Organicsalmost 22 years ago
Controlled-Release Dosage Forms for Diltiazem HydrochlorideNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
PharmTech Weekly Roundup - February 6, 2026
4
Women in STEM: Early Phase Drug Development
5